Monoclonal antibodies were prepared that recognize different age-related epitopes on proteoglycan subunits of high buoyant density isolated from human epiphysial and articular cartilages. Antibody and BCD-4. The amino acid and carbohydrate compositions of these proteoglycan fractions were different, and one (antibody-bound) resembled those of foetal and the other (antibody-unbound) resembled those of adult proteoglycans isolated from 24-27-week-old-foetal and 52-56-year-old-adult cartilage respectively. These observations demonstrate that human cartilages contain at least two chemically and immunochemically distinct populations of proteoglycans, the proportions and content of which are age-dependent. It is likely that these populations represent the products of different genes, though their heterogeneity may be compounded by the result of different post-translation modifications.
INTRODUCTION
Proteoglycans are major extracellular components of cartilage matrix. They consist of a central protein core to which chondroitin sulphate and keratan sulphate chains and N-and 0-linked oligosaccharides are covalently attached (Hascall, 1981; Hascall & Kimura, 1982) . Changes in proteoglycan structure have been observed in association with the maturation and aging of cartilage (Inerot et al., 1978; Bayliss & Ali, 1978; Sweet et al., 1979; Elliot & Gardener, 1979; Roughley & White, 1980; Garg & Swannn, 1981; Roughley, 1986) . These studies revealed that in older cartilage the proteoglycans are smaller, have shorter chondroitin sulphate chains and contain more keratan sulphate; they also contain more protein, the amino acid composition of which is different.
These structural changes result in a polydisperse and heterogeneous proteoglycan population in adult cartilage. There is evidence for the existence of more than one core protein, as indicated by studies with antibodies to proteoglycans (Hadhaizy et al., 1972; Hadhaizy & Glant, 1975; Champion et al., 1982) . The appearance of an additional population of proteoglycan subunits during aging has also been suggested by immunological methods employing cell-mediated immunity (Champion et al., 1982) and by biochemical studies in which two distinct populations have been separated (Bayliss et al., 1983; Heinegard et al., 1985 (Roughley & White, 1980) and high-buoyant-density proteoglycans () 1.6 g/ml) were isolated by using dissociative density-gradient centrifugation in 4 M-guanidinium chloride and CsCl (Hascall & Sajdera, 1969; Glant et al., 1986) .
Digestions of proteoglycan
Chondrotinase ABC was used at 0.1 unit/mg of proteoglycan in 0.1 M-sodium acetate/0.1 M-Tris/HCl buffer, pH 7.3 (Hascall & Heinegard, 1974 (Roughley & White, 1980) . Protein content was determined by the method of Lowry et al. (1951) , with bovine serum albumin as the standard.
Monoclonal antibodies
Antibodies were obtained from fusions of Sp2/0-Agl4 mouse myeloma cells and spleen cells of Balb/c mice immunized with foetal-human or adult-human cartilage proteoglycans as described previously (Glant et al., 1986) . The various monoclonal antibodies used in this study recognize different epitopes on foetal-human and/or adult-human cartilage proteoglycan. Immunoglobulin class and sublcass specificities of monoclonal antibodies, and the specificity of monoclonal antibodies to various epitopes, were determined by enzyme-linked immunosorbent assay (Glant et al., 1986 (Glant et al., 1986) . Sulphatases, alkaline phosphatase and neuraminidase had no effect on antibody binding to these two (BCD-4 and EFG-4) epitopes. Antibody azHFPG-846 (IgM) was prepared as before (Glant et al., 1986) by using mice immunized with foetal-human proteoglycan. Radioimmunoassay A competitive binding assay was used (Glant et al., 1986) . Briefly, optimal dilution of monoclonal antibody was incubated with a serial dilution of unlabelled proteoglycans overnight at 37 'C. 125I-labelled foetal or adult-human proteoglycans were then added for 2 h at 37 'C. Antigen-antibody complexes were bound to 25 ,ul of 10% (w/v) suspension of Protein A-bearing Staphylococcus aureus (Zysorbin; Dimension) as described previously (Glant et al., 1986) . In the case of IgM monoclonal antibodies, a tertiary immune complex was formed by rabbit immunoglobulin to mouse IgM (with the use of 100 ,u of 1: 25 dilution of immune serum), and this complex was pelleted by the Protein A method. Immuno-affinity chromatography Monoclonal antibody azHFPG-846 was purified on a hydroxyapatite column (Stanker et al., 1985) and coupled to CNBr-activated Sepharose CL-4B as described previously (Glant, 1982) . The proteoglycan-binding capacity of the column was determined, and native proteoglycan representing 50% of the maximal antigenbinding capacity was recirculated overnight at room temperature. Unbound proteoglycan was removed by exhaustive washing with 0.1 M-Tris/acetate buffer, pH 7.6, containing 0.5 M-NaCl, 0.05% 0.1% Triton X-100. Bound proteoglycan was eluted with 0.2 M-glycine/HCl buffer, pH 2.6, and immediately neutralized with 1.0 M-Tris (pH 8.0) and dialysed against deionized water. Samples were freeze-dried and stored at -20°C.
RESULTS
The preliminary characterization of monoclonal antibody axHFPG-846 is shown in Fig. 1 . The EFG-4 epitope was not found in proteoglycans of foetal cartilages before the third trimester of gestation. Close to its birth its quantity significantly increased, and this continued during the first year after birth until about 30 years of age, when it plateaued. The BCD-4 epitope was present in small amounts in foetal cartilage, but increased dramatically during development and reached a plateau at about 30 years of age. The latter change reflects the increase in keratan sulphate in human cartilage reported previously in biochemical studies (Bayliss & Ali, 1978; Elliott & Gardner, 1979; Roughley & White, 1980) . Epitope aHFPG-846 exhibited a peak up until about 27 weeks of foetal life, after which it decreased gradually, showing a more accelerated decline after birth up to 30 years of age. Only a trace amount could be detected in older cartilage.
This high-buoyant-density proteoglycan isolated from a 16-year-old-human cartilage contains each of the epitopes defined by the three monoclonal antibodies. This proteoglycan fraction was.separated intotwopopulations: one that bound to antibody acHFPG-846 (28% of the total)and onethatwasunbound (72% ). Onlyproteoglycan Vol. 236 that did not bind to antibody azHFPG-846 demonstrated clear binding to antibodies EFG-4 and BCD-4 ( Table 2 ), demonstrating that the epitopes recognized by these latter antibodies were on a population of molecules separate Binding of antibody aHFPG-846 to '251-labelled foetalhuman proteoglycan and that of antibodies EFG-4 and BCD-4 to '25I-labelled adult-human proteoglycan were inhibited by the bound and unbound proteoglycan subpopulations.
from those bearing the epitope recognized by antibody alHFPG-846. The two populations were then subjected to amino acid and carbohydrate analyses. These were compared with those of proteoglycans isolated from foetal cartilage (24-27 weeks' gestation) and adult cartilage (52-56 years of age). The results are shown in Table 3 . The proteoglycan that bound to the antibody was similar in its amino acid composition to that of the reference foetal proteoglycan. In contrast, the amino acid composition of the unbound proteoglycan was more similar to that of the adult cartilage proteoglycan, particularly in the content of its serine, glycine and isoleucine residues. In general, there was also a close correspondence between the sialic acid and uronic acid contents and galactosamine/glucosamine ratios for these matching pairs.
Inhibition ( (Heinegard et al., 1985) . Proteolytic modification of the proteoglycan within the extracellular matrix, or different post-translational glycosylation ofthe same core protein at different ages, may account for some of these and our observations. Nevertheless, the immunological differences between the two populations in maturing human cartilage seem more likely to represent different gene products. As the EFG-4 epitope is a repeating peptide associated with both the keratan sulphate-and chondroitin sulphate-linkage regions of the core protein, it is unlikely that proteolytic cleavages during aging can produce the differences detected by the monoclonal antibodies. Furthermore, the presence of a foetal-type epitope in the high-buoyant-density proteoglycans of foetal-human cartilage, which disappears completely as the adult-type epitopes accumulate, is difficult to explain by the variation in the activity of glycosyltransferases and sulphotransferases acting posttranslationally upon a single core protein. Two other monoclonal antibodies, which are specific for other foetal-human proteoglycan epitopes, have been isolated and demonstrate extremely similar changes to those described here for antibody ocHFPG-846 (T. T. Glant, K. Mikecz, P. J. Roughley, E. Buza's & A. R. Poole, unpublished work). Thus we have to suppose that the articular chondrocytes of maturing cartilage may switch to the production of a new core protein, initiating a concomitant change in glycosylation. Whether such a proteoglycan structure is more suitable for the function of the maturing articular cartilage is at present open to question.
